 Lisinopril
"Lisinopril" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure.
| Descriptor ID |
D017706
|
| MeSH Number(s) |
D12.644.456.345.600
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Lisinopril".
Below are MeSH descriptors whose meaning is more specific than "Lisinopril".
This graph shows the total number of publications written about "Lisinopril" by people in this website by year, and whether "Lisinopril" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1990 | 0 | 1 | 1 | | 1992 | 0 | 1 | 1 | | 1993 | 0 | 2 | 2 | | 1994 | 1 | 1 | 2 | | 1997 | 0 | 1 | 1 | | 2000 | 1 | 0 | 1 | | 2005 | 0 | 1 | 1 | | 2010 | 1 | 1 | 2 | | 2013 | 0 | 1 | 1 | | 2014 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Lisinopril" by people in Profiles.
-
Torres VE, Abebe KZ, Chapman AB, Schrier RW, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, Moore CG, Perrone RD. Angiotensin blockade in late autosomal dominant polycystic kidney disease. N Engl J Med. 2014 Dec 11; 371(24):2267-76.
-
Schrier RW, Abebe KZ, Perrone RD, Torres VE, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, Bae KT, Moore CG, Chapman AB. Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med. 2014 Dec 11; 371(24):2255-66.
-
Briasoulis A, Oliva R, Kalaitzidis R, Flynn C, Lazich I, Schlaffer C, Bakris G. Effects of nebivolol on aortic compliance in patients with diabetes and maximal renin angiotensin system blockade: the EFFORT study. J Clin Hypertens (Greenwich). 2013 Jul; 15(7):473-9.
-
Rosner GF, Garan AR, Uriel N. Letter by Rosner et al regarding article, "When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure". Circulation. 2013 Jan 29; 127(4):e431.
-
Miller AB, Reichek N, St John Sutton M, Iyengar M, Henderson LS, Tarka EA, Bakris GL. Importance of blood pressure control in left ventricular mass regression. J Am Soc Hypertens. 2010 Nov-Dec; 4(6):302-10.
-
Bakris GL, Iyengar M, Lukas MA, Ordronneau P, Weber MA. Effect of combining extended-release carvedilol and lisinopril in hypertension: results of the COSMOS study. J Clin Hypertens (Greenwich). 2010 Sep; 12(9):678-86.
-
Skirgello OE, Balyasnikova IV, Binevski PV, Sun ZL, Baskin II, Palyulin VA, Nesterovitch AB, Albrecht RF, Kost OA, Danilov SM. Inhibitory antibodies to human angiotensin-converting enzyme: fine epitope mapping and mechanism of action. Biochemistry. 2006 Apr 18; 45(15):4831-47.
-
Chang A, Logar CM, Finn LS, Alpers CE, Seliger SL. A rare cause of necrotizing and crescentic glomerulonephritis in a young adult male. Am J Kidney Dis. 2005 May; 45(5):956-60.
-
Bakris GL, Siomos M, Richardson D, Janssen I, Bolton WK, Hebert L, Agarwal R, Catanzaro D. ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group. Kidney Int. 2000 Nov; 58(5):2084-92.
-
Gao XP, Suzuki H, Olopade CO, Pakhlevaniants S, Rubinstein I. Angiotensin-converting enzyme and neutral endopeptidase modulate smokeless tobacco-induced increase in macromolecular efflux from the oral mucosa in vivo. J Lab Clin Med. 1997 Oct; 130(4):395-400.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|